Stock & Company Details
Enlivex Therapeutics Ltd $ENLV
Price:
N/A
N/A
17M
$5.5M
52 Week High:
N/A
10 Day Average Volume:
N/A
0.00
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
ENLV technical indicators
Latest Enlivex Therapeutics Ltd (ENLV) indicator readings as of 2026-10-09.
ENLV's 14-day RSI is 17.5, in oversold territory. At $0.25 it is trading 79.9% below its 200-day moving average of $1.26, and below its 50-day average of $1.16. Price sits near the lower Bollinger Band ($0.16 to $0.95). ADX reads 48.6, indicating a trending market.
Overview
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.
Finance Bot
Ask your questions
Start by typing a question below.
